<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> may progress to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Photodynamic therapy is a promising treatment for BE </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: To determine if photodynamic therapy is an acceptable alternative to esophagectomy in BE patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or early <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Seventeen patients were treated with photodynamic therapy for BE and high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or early esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with residual Barrett's epithelium were treated with supplemental <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation or <z:chebi fb="120" ids="26216">potassium</z:chebi> titanyl phosphate laser </plain></SENT>
<SENT sid="5" pm="."><plain>Patients underwent follow-up endoscopy three, six, nine and 12 months post-treatment, then every six to 12 months </plain></SENT>
<SENT sid="6" pm="."><plain>Mean follow-up was 21 months </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: High-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or early <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> was completely eliminated in nine of 15 (60%) patients </plain></SENT>
<SENT sid="8" pm="."><plain>High-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was downgraded in one patient, persisted in one patient and progressed in four patients </plain></SENT>
<SENT sid="9" pm="."><plain>Two patients with early esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> were nonresponders </plain></SENT>
<SENT sid="10" pm="."><plain>Complications included stricture, sunburn, <z:hpo ids='HP_0001025'>urticaria</z:hpo>, small <z:hpo ids='HP_0002202'>pleural effusions</z:hpo>, <z:e sem="disease" ids="C0014863" disease_type="Disease or Syndrome" abbrv="">esophageal spasm</z:e> and transient <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Photodynamic therapy with supplemental ablation is a good, noninvasive therapy for elimination of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and early <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in BE </plain></SENT>
<SENT sid="12" pm="."><plain>Failure to eliminate dysplastic epithelium occurred in 40% of the patients, thereby necessitating careful follow-up </plain></SENT>
</text></document>